Is t(11;14)(q13;q32) good or bad for newly diagnosed multiple myeloma?

Is t(11;14)(q13;q32) good or bad for newly diagnosed multiple myeloma?

Bibliographic Details
Main Authors:	Yang Liu, Lu Gao, Yueyun Lai, Lei Wen, Wenbing Duan, Fengrong Wang, Ling Ma, Xiaojun Huang, Jin Lu, Peng Lyu, Yuanyuan Ji
Format:	Article
Language:	English
Published:	Wolters Kluwer 2023-01-01
Series:	Chinese Medical Journal
Online Access:	http://journals.lww.com/10.1097/CM9.0000000000002159

Similar Items

Translocation t(11;14) (q13;q32) and genomic imbalances in multi-ethnic multiple myeloma patients: a Malaysian study
by: Ivyna Bong Pau Ni, et al.
Published: (2012-09-01)

CD20 expression: A risk stratification factor for newly diagnosed multiple myeloma with t(11;14)
by: Yuan Jian, et al.
Published: (2022-12-01)

Plasma cell leukemia with t(11;14)(q13;q32) simulating lymphoplasmacytic lymphoma – a diagnostic challenge solved by flow cytometry
by: Aleyde Diniz Loureiro, et al.

IgE Plasma Cell Leukemia Harboring t(11;14) and 1q Amplification
by: Wataru Nakahara, et al.
Published: (2023-01-01)

The Role of t(11;14) in Tailoring Treatment Decisions in Multiple Myeloma
by: Martina Kleber, et al.
Published: (2023-12-01)

Multiple myeloma with t(11;14): impact of novel agents on outcome
by: Borja Puertas, et al.
Published: (2023-03-01)

Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)
by: Nina Nguyen, et al.
Published: (2022-10-01)

Incidence and effect of secondary cardiac amyloidosis on outcomes of patients with t(11;14) multiple myeloma
by: Jinghua Wang, et al.
Published: (2022-09-01)

Exploring the current molecular landscape and management of multiple myeloma patients with the t(11;14) translocation
by: Michael D. Diamantidis, et al.
Published: (2022-08-01)

Prognostic value of 13q14 deletion and IgH 14q32 rearrangement by interphase fluorescence in situ hybridization in patients with multiple myeloma
by: Nevine A Kassem, et al.
Published: (2014-01-01)

P22 THE PROGNOSTIC ROLE OF 1Q ABNORMALITIES IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
by: I. Attucci, et al.
Published: (2023-05-01)

A case of de novo microdeletion with combination of 1q21.1 and 14q32.2q32.31
by: Hale Onder Yilmaz, et al.
Published: (2020-12-01)

The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gain
by: Hoi Ki Karen Tang, et al.
Published: (2022-03-01)

Evaluating the difference in clinical efficacy for t(11;14) multiple myeloma patients with CD20- or CD20+
by: ZHAO Weihong, HUANG Bintao, LIU Rui, XIANG Caixia
Published: (2023-09-01)

The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients
by: Hongying You, et al.
Published: (2022-10-01)

Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy
by: Ghulam Rehman Mohyuddin, et al.
Published: (2022-12-01)

Intellectual disability in two Chinese sisters caused by a 3p26.3p25.3 microdeletion and a 14q32.13q32.33 microduplication inherited from the mother with 46, XX, t (3, 14) (p25; q32)
by: Ying Dai, et al.
Published: (2020-08-01)

Advancing the understanding of venetoclax in t(11;14)-positive multiple myeloma: a comprehensive review of clinical evidence and future prospects
by: Abdullah AlZahrani, et al.
Published: (2024-12-01)

Near tetrapoloid karyotype with translocation t(11;14) in a Moroccan patient with amyloid light-chain amyloidosis and multiple myeloma
by: Hasna Hamdaoui, et al.
Published: (2020-01-01)

Chronic Lymphocytic Leukemia with t(14;18)(q32;q21) As a Sole Cytogenetic Abnormality
by: Ghaleb Elyamany, et al.
Published: (2014-09-01)

Chronic Lymphocytic Leukemia with t(14;18)(q32;q21) as a Sole Cytogenetic Abnormality
by: Ghaleb Elyamany, et al.
Published: (2014-01-01)

Prognosis influence of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia with t(15;17)(q24;q21)
by: Lin Liu, et al.
Published: (2024-12-01)

miRNAs in the 14q32 cluster are involved in lapatinib resistance
by: Chupin, J, et al.
Published: (2017)

Amplification of 3q26.2, 5q14.3, 8q24.3, 8q22.3, and 14q32.33 Are Possible Common Genetic Alterations in Oral Cancer Patients
by: Melvin A. Ambele, et al.
Published: (2020-04-01)

Combination of t(4;14), del(17p13), del(1p32) and 1q21 gain FISH probes identifies clonal heterogeneity and enhances the detection of adverse cytogenetic profiles in 233 newly diagnosed multiple myeloma
by: Thomas Smol, et al.
Published: (2017-07-01)

Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimens
by: Xiao Liu, et al.
Published: (2022-09-01)

P832: PROSPECTIVE REAL-WORLD EVALUATION OF THE PREVALENCE OF T(11;14) IN MULTIPLE MYELOMA: THIRD INTERIM ANALYSIS FROM THE MEDICI STUDY
by: Maria Gavriatopoulou, et al.
Published: (2023-08-01)

Essential Role of the 14q32 Encoded miRNAs in Endocrine Tumors
by: Lilla Krokker, et al.
Published: (2021-05-01)

Downregulation of 14q32 microRNAs in primary human desmoplastic medulloblastoma.
by: Danielle Ribeiro Lucon, et al.
Published: (2013-09-01)

Prenatal diagnosis and molecular cytogenetic characterization of a de novo interstitial duplication of 14q (14q31.3→q32.12) associated with abnormal maternal serum biochemistry
by: Chih-Ping Chen, et al.
Published: (2013-03-01)

A Case of B-cell Precursor Acute Lymphoblastic Leukemia with the t(14;22)(q32;q11) Presenting Hyperleukocytosis
by: Jianne Lee, et al.
Published: (2022-10-01)

Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia
by: Janek S. Walker, et al.
Published: (2021-11-01)

The prognostic impact of t(11;14) in multiple myeloma: A real‐world analysis from the Australian Lymphoma Leukaemia Group (ALLG) and the Australian Myeloma and Related Diseases Registry (MRDR)
by: Kenneth JC Lim, et al.
Published: (2023-08-01)

Transcriptomic Analysis in Multiple Myeloma and Primary Plasma Cell Leukemia with t(11;14) Reveals Different Expression Patterns with Biological Implications in Venetoclax Sensitivity
by: Katia Todoerti, et al.
Published: (2021-09-01)

Acquired platelet dysfunction in newly diagnosed myeloma
by: Joshua Mortimer, et al.
Published: (2021-02-01)

Daratumumab in untreated newly diagnosed multiple myeloma
by: Nadine Abdallah, et al.
Published: (2019-12-01)

MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma
by: Sarver Aaron L, et al.
Published: (2013-01-01)

Prenatal diagnosis and molecular cytogenetic characterization of a de novo 3.19-Mb chromosome 14q32.13-q32.2 deletion of paternal origin
by: Chih-Ping Chen, et al.
Published: (2020-09-01)

Good Cop, Bad Cop: Profiling the Immune Landscape in Multiple Myeloma
by: Niyati Seshagiri Sharma, et al.
Published: (2023-11-01)

Mantle cell lymphoma negative for t(11,14) involving the kidneys: a case report
by: Hasan Nassereldine, et al.
Published: (2022-06-01)